Biotechnology company Clinical Data Inc. said the Food and Drug Administration approved the major depressive disorder treatment Viibryd. The company said the drug should be available in U.S. pharmacies in the second quarter.
Rexahn Pharmaceuticals Inc. said that Teva Pharmaceutical Industries Ltd. bought $3.95 million of the company's stock in a private offering. The investment gives Teva a 6.29 percent ownership stake in Rexahn.
Lupus drug developer Human Genome Sciences Inc. said it appointed former Wyeth Chief Financial Officer Greg Norden to its board of directors.
The Food and Drug Administration has asked Vivus Inc. to study the rate of side effects associated with one of the ingredients of its obesity drug candidate, Qnexa.
A regulatory committee recommended that a seizure drug developed by GlaxoSmithKline and Valeant Pharmaceuticals be approved in the European Union, the companies said.
Drugmaker Watson Pharmaceuticals Inc. said it expects 2011 global revenue to climb in both its generic and branded segments, following a year in which net revenue grew 25 percent.
Swiss drug maker Novartis AG said it is paying $470 million to acquire U.S. cancer diagnostic specialist Genoptix Inc. Novartis will pay $25 per share to acquire all of the Carlsbad, California-based company's outstanding stock.
An advisory panel's recommendation that the U.S. Food and Drug Administration approve a new chemical that can highlight the telltale signs of Alzheimer's in brain scans may one day help doctors diagnose the neurodegenerative disease, experts said.
Biochrom Ltd announces further functionality in its microplate readers that now enable users of Abcam’s popular ELISA assays to download pre-programmed method definitions.
nanoTherics has announced the launch of the magnefect-LT. This device offers gene transfection with improved efficiencies and cell viabilities, even with difficult cells types including neuronal and primary cells.
Theraclone Sciences, Inc. has entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone’s I-STAR technology to discover broadly protective monoclonal antibodies.
Six pharmaceutical manufacturing facilities constructed in Germany, Switzerland, Sweden, and the USA have been selected as Category Winners in the seventh annual Facility of the Year Awards (FOYA) program sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine.
MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.
Convalescent plasma therapy—using plasma from patients who have recovered from an infection to treat those with the same infection—has been used to treat multiple diseases.
A recent study by researchers from Case Western Reserve University and scientists at Athersys, presents data supporting the potential therapeutic benefit of the MultiStem program for spinal cord injury.